Skip to content

Public FDA record

Z-2583-2024: HeartMate 3 System Controllers provided within the following HeartMate 3 Left Ventricular Assist System (

Recall record Z-2583-2024 for Thoratec LLC. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-2583-2024
Company in FDA record
Thoratec LLC
FDA classification date
Aug 13, 2024
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

Left ventricular assist system controller UI membrane/screen may lift along the edge of the controller housing, and if controller is exposed to fluid, ingress may occur, which may damage printed circuit board assemblies, which could result in unexpected and false positive alarms, loss of visual alarms, loss of user interface(use of buttons, loss of visual alarms,etc.), loss of power, and pump stop

Source facts

Action
On 6/25/24, verbal and email communications were initiated informing customers of the following: 1) Carefully inspect the controller at the edge near the display button to confirm the UI membrane is not lifted (refer to provided visual examples). 2) Report Controllers with lifted UI membrane by contacting Firm's Technical Support at 1-800-456-1477. 3) Reinforce requirement as listed on Page 2-11 "System Controller Warnings and Cautions" in the IFU to patients to protect controller from water. Advise them to follow instructions to avoid direct exposure to water; and communicate risk of continuous, steady exposure to water. 4) Reinforce requirement to patient to perform the daily self-test to verify the display works appropriately as listed on Page 2-29 "Performing a System Controller Self Test". Patients should contact the hospital in the event of display issues. Firm will follow-up with a formal notification about the lifted UI membrane.
Initiated
2024-06-25
Root cause
Process design
Distribution
US: MN, PA, FL, IL, NY, DE, AR, NJ, NC, GA, WI, AZ, TN, MO, TX, MA, OH, VA, NE, CA, OK, CO, DC, IN, MI, CT, UT, IA, MD, OR, NM, ME, SC, KY, LA, WA, NV, HI, AL, MS, KS, WV. OUS: Algeria, Australia, Austria, Bahrain, Bangladesh, Belgium, Bosnia & Herzegovina, Brazil, Bulgaria, Canada, Cayman Islands, Chile, Colombia, Croatia, Cyprus, Czech Republic, Denmark, Egypt, Estonia, Finland, France, Germany, Greece, Hong Kong, India, Iran, Islamic Republic of, Iraq, Ireland, Israel, Italy, Korea, Kuwait, Lebanon, Lithuania, Macedonia, Morocco, Netherlands, New Zealand, Norway, Oman, Palestine, Poland, Portugal, Qatar, Romania, Russian Federation, Saudi Arabia, Serbia, Slovenia, South Africa, Spain, Sweden, Switzerland, Taiwan, Tunisia, Turkey, United Arab Emirates, United Kingdom, Uzbekistan
Recall number
Z-2583-2024
Recall status
Open, Classified
CDRH record ID
208997
FDA classified
2024-08-13
Recall event number
94973

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗